Seeing Is Believing
with an average price target of $16.2. This is a potential upside of $2.98 (22.54%) from yesterday's end of day stock price of $13.22.
Magenta Therapeutics's activity chart (see below) currently has 5 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 110 days.
Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 26-Jan-2023. First documented stock forecast 16-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$1
$0.3 (42.86%)
$9
2 years 2 months 30 days ago
(26-Jan-2023)
0/4 (0%)
$0.56 (127.27%)
Hold
$3
2 years 2 months 30 days ago
(26-Jan-2023)
2/3 (66.67%)
$-2.8 (-48.28%)
266
Hold
$2
$1.3 (185.71%)
$7
2 years 8 months ago
(25-Aug-2022)
1/3 (33.33%)
$0.13 (6.95%)
14
Buy
$8
$7.3 (1042.86%)
$17
3 years 7 days ago
(18-Apr-2022)
0/3 (0%)
$6.08 (316.67%)
Buy
$8
$7.3 (1042.86%)
$17
3 years 11 days ago
(14-Apr-2022)
0/2 (0%)
$5.76 (257.14%)
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?